Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Physician Services | 1,336.8 | 512.0 | | | | | | |
Ambulatory Services | 1,230.1 | 1,109.9 | 1,057.2 | 899.2 | | | | |
Total revenues [+] | 2,566.9 | 1,621.9 | 1,057.2 | 899.2 | 772.1 | 692.6 | 650.3 | 588.7 |
Services | | | | | 772.1 | 692.6 | 650.3 | 588.7 |
Healthcare | 2,833.0 | 1,739.0 | 1,057.2 | 899.2 | | | | |
Revenue growth [+] | 58.3% | 53.4% | 17.6% | 16.5% | 11.5% | 6.5% | 10.5% | 13.7% |
Physician Services | 161.1% | | | | | | | |
Ambulatory Services | 10.8% | 5.0% | 17.6% | | | | | |
Cost of goods sold [+] | 1,896.4 | 1,143.8 | 697.2 | 597.3 | 508.4 | 444.7 | 330.2 | 292.0 |
Labor costs | 1,314.4 | 694.6 | 327.6 | 284.5 | 238.7 | 209.1 | 196.0 | 170.5 |
Sales commissions and fees | 1,314.4 | 694.6 | 327.6 | 284.5 | 238.7 | | | 170.5 |
Other cost of sales | 397.8 | 284.9 | 216.5 | 185.9 | 168.3 | 145.8 | 134.3 | 121.6 |
Supplies costs | 184.2 | 164.3 | 153.1 | 126.9 | 101.4 | 89.9 | | |
Other direct costs | 397.8 | 284.9 | 216.5 | 185.9 | 168.3 | 145.8 | 134.3 | 121.6 |
Gross profit | 670.5 | 478.1 | 360.0 | 301.9 | 263.6 | 247.8 | 320.1 | 296.6 |
Gross margin | 26.1% | 29.5% | 34.1% | 33.6% | 34.1% | 35.8% | 49.2% | 50.4% |
Selling, general and administrative | 97.5 | 60.3 | 32.4 | 29.3 | 25.6 | 24.7 | 22.4 | 20.2 |
Equity in earnings | 16.2 | 7.0 | 3.2 | 1.6 | 0.6 | | | |
Other operating expenses | -187.0 | -74.2 | -40.0 | -30.8 | -26.3 | -24.7 | 56.7 | 49.1 |
EBITDA [+] | 760.0 | 492.0 | 367.6 | 303.5 | 264.2 | 247.8 | 241.1 | 227.4 |
EBITDA growth | 54.5% | 33.8% | 21.1% | 14.9% | 6.6% | 2.8% | 6.0% | 13.8% |
EBITDA margin | 29.6% | 30.3% | 34.8% | 33.8% | 34.2% | 35.8% | 37.1% | 38.6% |
Depreciation | 27.0 | 27.8 | 30.2 | 27.9 | 24.2 | 23.5 | 21.9 | 20.2 |
EBITA | 733.0 | 464.2 | 337.4 | 275.6 | 240.1 | 224.4 | 219.2 | 207.2 |
EBITA margin | 28.6% | 28.6% | 31.9% | 30.7% | 31.1% | 32.4% | 33.7% | 35.2% |
Amortization of intangibles | 70.5 | 32.5 | 2.2 | 1.4 | 1.5 | 1.2 | 0.5 | |
EBIT [+] | 662.5 | 431.7 | 335.2 | 274.2 | 238.6 | 223.2 | 218.7 | 207.2 |
EBIT growth | 53.5% | 28.8% | 22.2% | 14.9% | 6.9% | 2.0% | 5.5% | 14.4% |
EBIT margin | 25.8% | 26.6% | 31.7% | 30.5% | 30.9% | 32.2% | 33.6% | 35.2% |
Non-recurring items [+] | 45.0 | 37.3 | 2.5 | 0.7 | | | | |
Unusual expense | 36.7 | 3.4 | 2.2 | | | | | |
Interest expense | 121.6 | 83.3 | 29.5 | 17.0 | 15.3 | 13.5 | 7.8 | 9.7 |
Interest expense | 121.6 | 83.3 | 29.5 | 17.0 | 15.3 | 13.5 | 7.8 | 9.7 |
Other income (expense), net [+] | | -16.9 | | | | | | |
Gain (loss) on debt retirement | | 16.9 | | | | | | |
Pre-tax income | 495.9 | 294.2 | 303.1 | 256.6 | 223.3 | 209.7 | 210.9 | 197.5 |
Income taxes | 113.8 | 48.1 | 48.7 | 40.9 | 35.0 | 33.0 | 34.3 | 32.5 |
Tax rate | 22.9% | 16.4% | 16.0% | 15.9% | 15.7% | 15.7% | 16.3% | 16.4% |
Minority interest | 218.2 | 191.1 | 188.8 | 161.1 | 140.1 | 130.7 | 129.2 | 118.9 |
Earnings from continuing ops | 154.9 | 50.5 | 65.7 | 54.6 | 48.2 | 46.0 | 47.4 | 48.0 |
Earnings from discontinued ops | -1.0 | -1.3 | 7.1 | 7.9 | 1.8 | 3.8 | 4.8 | -0.9 |
Net income | 153.9 | 49.2 | 72.7 | 62.6 | 50.0 | 49.8 | 52.1 | 47.0 |
Net margin | 6.0% | 3.0% | 6.9% | 7.0% | 6.5% | 7.2% | 8.0% | 8.0% |
|
Basic EPS [+] | $3.22 | $1.28 | $2.09 | $1.77 | $1.58 | $1.52 | $1.55 | $1.52 |
Growth | 150.9% | -38.7% | 18.0% | 12.2% | 4.0% | -1.8% | 1.8% | -100.0% |
Diluted EPS [+] | $3.00 | $1.27 | $2.05 | $1.73 | $1.54 | $1.50 | $1.54 | $1.50 |
Growth | 135.5% | -38.0% | 18.9% | 11.9% | 2.9% | -2.3% | 2.3% | -100.0% |
|
Shares outstanding (basic) [+] | 48.1 | 39.3 | 31.3 | 30.8 | 30.5 | 30.3 | 30.6 | 31.5 |
Growth | 22.3% | 25.4% | 1.8% | 1.1% | 0.7% | -1.0% | -2.9% | 1108869.5% |
Shares outstanding (diluted) [+] | 51.6 | 39.6 | 32.0 | 31.6 | 31.2 | 30.7 | 30.9 | 32.0 |
Growth | 30.3% | 24.0% | 1.1% | 1.3% | 1.7% | -0.6% | -3.4% | 1125062.5% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|